Sun Pharmaceutical (SUNPHARMA) — Announcement

📢 Key Event
Court affirms summary judgment in Sun Pharma's favor on Lipitor antitrust case

💡 Investor Takeaway
The settlement removes a major legal risk, potentially supporting long-term valuation and investor confidence.

Sun Pharmaceutical announced that the US Court of Appeals affirmed summary judgment in its favor regarding the Lipitor antitrust litigation, concluding the case and removing a long-standing legal cloud over the company's US operations. This resolves a key uncertainty that had weighed on investor sentiment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,69,309.92 Cr P/E: 38.8 ROE: 14.6% ROCE: 18.7% Div Yield: 0.82%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this ruling impact Sun Pharma's US revenue outlook?" "What is the potential financial exposure from remaining litigation?" "How does this compare to similar antitrust case resolutions?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 17 August 2026

PREMIERENE Premier Energies Limited Announcement ABCAPITAL Aditya Birla Capital Limited Corporate Action VIVIMEDLAB Vivimed Labs Limited Announcement GSPCROP GSP Crop Science Limited Financial Results SEDEMAC SEDEMAC Mechatronics Limited Annual Report AFFLE Affle 3i Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUNPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd